DSM-Firmenich AG
F:ZX6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DSM-Firmenich AG
F:ZX6
|
CH |
|
M
|
MongoDB Inc
SWB:526
|
US |
|
M
|
MillerKnoll Inc
XBER:MHR
|
US |
|
S
|
Swire Pacific Ltd
OTC:SWRAY
|
HK |
|
Koninklijke Philips NV
OTC:RYLPF
|
NL |
|
Molina Healthcare Inc
NYSE:MOH
|
US |
|
Delegat Group Ltd
NZX:DGL
|
NZ |
Wall St Price Targets
ZX6 Price Targets Summary
DSM-Firmenich AG
According to Wall Street analysts, the average 1-year price target for ZX6 is 80.36 EUR with a low forecast of 65.46 EUR and a high forecast of 94.22 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZX6's stock price target?
Price Target
80.36
EUR
According to Wall Street analysts, the average 1-year price target for ZX6 is 80.36 EUR with a low forecast of 65.46 EUR and a high forecast of 94.22 EUR.
What is the Revenue forecast for DSM-Firmenich AG?
Projected CAGR
6%
Over the last 3 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Gross Profit forecast for DSM-Firmenich AG?
Projected CAGR
7%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for DSM-Firmenich AG?
Projected CAGR
25%
Over the last 3 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 25%.
What is the Pre-Tax Income forecast for DSM-Firmenich AG?
Projected CAGR
25%
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 25%.
